The MarketWatch News Department was not involved in the creation of this content. LEO Pharma Presents Final Results of ECZTEND Long-Term Adbry(R) Trial (tralokinumab-ldrm) in Patients with Moderate-to ...
The Adbry autoinjector is for use in adults only. A new single-dose autoinjector presentation of Adbry ® (tralokinumab-ldrm) is now available for use in the treatment of moderate to severe atopic ...
MADISON, N.J.--(BUSINESS WIRE)--LEO Pharma A/S, a global leader in medical dermatology, will present a catalog of investigational delgocitinib cream and Adbry ® data across 10 posters at the upcoming ...
Verywell Health on MSN
Biologics for eczema and how they work
Medically reviewed by Patricia Mikula, PharmD Key Takeaways Biologics are used for people with severe eczema when other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback